Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AURA INVESTMENTS LTD. (AURA)

  • Business News
  • Aug. 12, 2026, 06:00 UTC
  • 6
  • 1 comments

Dormant shares – change in the number of shares

Market reaction Comment Full text

TUNIU CORP (TOUR)

  • Business News
  • Aug. 12, 2026, 06:00 UTC
  • 6
  • 1 comments

Tuniu to Report Second Quarter 2026 Financial Results on August 25, 2026

Market reaction Comment Full text

ASHTROM GROUP LTD (ASHG)

  • Business News
  • Aug. 12, 2026, 05:58 UTC
  • 5
  • 1 comments

Binding agreement for the sale of 20% of Ashtrom Rental Housing to entities from the Migdal group, continuation

Market reaction Comment Full text

SCOPE METALS GROUP LTD (SCOP)

  • Business News
  • Aug. 12, 2026, 05:52 UTC
  • 6
  • 1 comments

The company’s liability position as of 30.6.26, by maturity dates

Market reaction Comment Full text

OIL REFINERIES LTD. (ORL)

  • Business News
  • Aug. 12, 2026, 05:51 UTC
  • 6
  • 1 comments

Investors presentation - Second quarter 2026

Market reaction Comment Full text

SCOPE METALS GROUP LTD (SCOP)

  • Business News
  • Aug. 12, 2026, 05:48 UTC
  • 4
  • 1 comments

Quarter 2/semi-annual report for 2026

Market reaction Comment Full text

OIL REFINERIES LTD. (ORL)

  • Business News
  • Aug. 12, 2026, 05:45 UTC
  • 2
  • 1 comments

Dividend of $0.03844 per share, record date: 20.8.26, payment 3.9.26

Market reaction Comment Full text

BEZEQ THE ISRAELI TELECOMMUNICATION CORP. LTD. (BEZQ)

  • Business News
  • Aug. 12, 2026, 05:43 UTC
  • 4
  • 1 comments

Dormant shares - creation of dormant shares

Market reaction Comment Full text

FIRST INTERNATIONAL BANK OF ISRAEL LTD. (FIBI)

  • Business News
  • Aug. 12, 2026, 05:43 UTC
  • 4
  • 1 comments

Preliminary notice of intention to convene a general meeting for the approval of the appointment of directors

Market reaction Comment Full text

MILUNA ACQUISITION CORP (MMTX)

  • Business News
  • Aug. 12, 2026, 05:39 UTC
  • 4
  • 1 comments

MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

Market reaction Comment Full text
  • Previous
  • 1094
  • 1095
  • 1096
  • 1097
  • 1098
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235219)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin